Bimekizumab Treatment Is Associated with Improvements in Back Pain and Fatigue in Patients with Active Psoriatic Arthritis: 48-Week Results from a Phase 2b Study

被引：0
|
作者：
Deodhar, Atul [1 ]
Gossec, Laure [2 ,3 ]
Mease, Philip [4 ]
Coarse, Jason [5 ]
Edens, Heather [6 ]
De Peyrecave, Natasha [7 ]
Assudani, Deepak [7 ]
Ink, Barbara [7 ]
Ritchlin, Christopher [8 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Sorbonne Univ, Paris, France
[3] Hop Univ Pitie Salpetriere, Paris, France
[4] Seattle Rheumatol Associates PLLC, Seattle, WA USA
[5] UCB Pharma, Raleigh, NC USA
[6] UCB Pharma, Smyrna, GA USA
[7] UCB Pharma, Slough, Berks, England
[8] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0906
引用
收藏
页数：4
相关论文
共 50 条
  • [31] The Effect of Guselkumab on Enthesitis: Results from a Phase 2 Study in Patients with Active Psoriatic Arthritis
    Helliwell, Philip
    Gottlieb, Alice B.
    Deodhar, Atul A.
    Boehncke, Wolf-Henning
    McGonagle, Dennis
    Xu, Xie L.
    Xu, Stephen
    Wang, Yuhua
    Hsia, Elizabeth C.
    Karyekar, Chetan S.
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] THE EFFECT OF GUSELKUMAB ON DACTYLITIS: RESULTS FROM A PHASE 2 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Gladman, Dafna
    Boehncke, Wolf-Henning
    Gottlieb, Alice B.
    Helliwell, Philip
    Nash, Peter
    Lawson, Fabio Lorea
    Xu, Stephen
    Hsia, Elizabeth
    Karyekar, Chetan
    Deodhar, Atul
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S66 - S66
  • [33] The effect of guselkumab on psoriasis in patients with active psoriatic arthritis: Results from a phase 2 study
    Gottlieb, A. B.
    Boehncke, W-H.
    Helliwell, P.
    Deodhar, A.
    Xu, X. L.
    Xu, S.
    Wang, Y.
    Zhuang, Y.
    Hsia, E. C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB131 - AB131
  • [34] THE EFFECT OF GUSELKUMAB ON ENTHESITIS: RESULTS FROM A PHASE 2 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Helliwell, Philip
    Gottlieb, Alice B.
    Deodhar, Atul
    Boehncke, Wolf-Henning
    McGonagle, Dennis
    Lawson, Fabio L.
    Xu, Stephen
    Hsia, Elizabeth
    Karyekar, Chetan
    Mease, Philip
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S65 - S66
  • [35] THE EFFECT OF GUSELKUMAB ON ENTHESITIS: RESULTS FROM A PHASE 2 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Helliwell, P.
    Gottlieb, A. B.
    Deodhar, A.
    Boehncke, W. -H.
    McGonagle, D.
    Xu, X. L.
    Xu, S.
    Wang, Y.
    Hsia, E. C.
    Karyekar, C. S.
    Mease, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1037 - 1037
  • [36] THE EFFECT OF GUSELKUMAB ON DACTYLITIS: RESULTS FROM A PHASE 2 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Gladman, D.
    Boehncke, W. -H.
    Gottlieb, A. B.
    Helliwell, P.
    Nash, P.
    Xu, X. L.
    Xu, S.
    Wang, Y.
    Hsia, E. C.
    Karyekar, C. S.
    Deodhar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1025 - 1026
  • [37] Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies
    McInnes, Iain B.
    Mease, Philip J.
    Tanaka, Yoshiya
    Gossec, Laure
    Husni, M. Elaine
    Kristensen, Lars Erik
    Warren, Richard B.
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Gottlieb, Alice B.
    ACR OPEN RHEUMATOLOGY, 2024, 6 (11) : 720 - 731
  • [38] Achievement of increasingly stringent clinical disease control criteria was associated with greater improvements in physical function, pain and fatigue in patients with active psoriatic arthritis: 52-Week results from BE OPTIMAL, a phase 3 randomised, placebo-controlled study
    Kristensen, L. E.
    Coates, L. C.
    Mease, P. J.
    Merola, J. F.
    Gisondi, P.
    Nash, P.
    Orbai, A. M.
    Tillett, W.
    Ink, B.
    Bajracharya, R.
    Taieb, V
    Lambert, J.
    Willems, D.
    Mottis, A.
    Walsh, J. A.
    SWISS MEDICAL WEEKLY, 2023, 153 : 24S - 24S
  • [39] ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL DISEASE CONTROL CRITERIA WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION, PAIN AND FATIGUE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM BE OPTIMAL, A PHASE 3 RANDOMISED, PLACEBO-CONTROLLED STUDY
    Kristensen, L. E.
    Coates, L.
    Mease, P. J.
    Merola, J. F.
    Gisondi, P.
    Nash, P.
    Orbai, A. M.
    Tillett, W.
    Ink, B.
    Bajracharya, R.
    Taieb, V.
    Lambert, J.
    Willems, D.
    Walsh, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1776 - 1777
  • [40] EFFICACY AND SAFETY OF 108 WEEKS' BIMEKIZUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: INTERIM RESULTS FROM A PHASE 2 OPEN-LABEL EXTENSION STUDY
    Mcinnes, I.
    Merola, J. F.
    Mease, P. J.
    Coates, L. C.
    Joshi, P.
    Coarse, J.
    Ink, B.
    Ritchlin, C. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1149 - 1150
12345